NCT07216794View on ClinicalTrials.gov

Small Trial of Alendronate Impact on the Reservoir of HIV

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 17, 2026

Primary Completion Date

March 26, 2027

Study Completion Date

May 21, 2027

Conditions
HIV
Interventions
DRUG

Alendronate

70 mg oral capsules

OTHER

Placebo

Matching ALN placebo oral capsules

Trial Locations (5)

15213

University of Pittsburgh (Site ID: 1001), Pittsburgh

27599

Chapel Hill (Site ID: 3201), Chapel Hill

43210

Ohio State University (Site ID: 2301), Columbus

80045

University of Colorado Hospital (Site ID: 6101), Aurora

94110

University of California, San Francisco HIV/AIDS (Site ID: 801), San Francisco

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH